athenahealth, Inc. (ATHN) Price Target Cut to $120.00 by Analysts at Jefferies Group LLC

athenahealth, Inc. (NASDAQ:ATHN) had its price objective reduced by Jefferies Group LLC from $135.00 to $120.00 in a report published on Friday morning. They currently have a hold rating on the health services provider’s stock. Jefferies Group also issued estimates for athenahealth’s Q3 2017 earnings at $0.25 EPS.

Several other equities research analysts have also issued reports on the stock. Citigroup Inc. reissued a buy rating and issued a $169.00 price target (up previously from $163.00) on shares of athenahealth in a report on Monday, July 10th. BidaskClub raised shares of athenahealth from a hold rating to a buy rating in a report on Saturday, June 24th. William Blair reissued a market perform rating on shares of athenahealth in a report on Friday, July 21st. J P Morgan Chase & Co set a $136.00 price target on shares of athenahealth and gave the company a hold rating in a report on Wednesday, July 19th. Finally, Evercore ISI reissued an outperform rating and issued a $147.00 price target (up previously from $118.00) on shares of athenahealth in a report on Friday, May 19th. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and thirteen have issued a buy rating to the stock. The company has an average rating of Hold and an average target price of $148.41.

athenahealth (NASDAQ ATHN) traded down 1.49% on Friday, hitting $128.94. 399,272 shares of the stock traded hands. The stock has a 50-day moving average of $139.00 and a 200-day moving average of $128.87. athenahealth has a 12-month low of $90.11 and a 12-month high of $158.66. The firm has a market cap of $5.15 billion, a price-to-earnings ratio of 163.63 and a beta of 1.79.

athenahealth (NASDAQ:ATHN) last announced its quarterly earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.39 by $0.12. The firm had revenue of $301.10 million for the quarter, compared to analyst estimates of $298.68 million. athenahealth had a net margin of 2.80% and a return on equity of 6.91%. The business’s revenue for the quarter was up 15.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.34 EPS. Analysts forecast that athenahealth will post $1.91 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This news story was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at https://www.chaffeybreeze.com/2017/09/16/athenahealth-inc-athn-price-target-cut-to-120-00-by-analysts-at-jefferies-group-llc.html.

In other athenahealth news, SVP Jonathan D. Porter sold 300 shares of the company’s stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $143.13, for a total transaction of $42,939.00. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Jonathan Bush sold 4,000 shares of the company’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $143.31, for a total transaction of $573,240.00. Following the transaction, the chief executive officer now owns 319,807 shares in the company, valued at $45,831,541.17. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,422 shares of company stock worth $2,182,607. Insiders own 3.20% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in the business. Toronto Dominion Bank acquired a new position in athenahealth during the 2nd quarter valued at about $16,863,000. 1st Global Advisors Inc. acquired a new position in athenahealth during the 2nd quarter valued at about $243,000. Verition Fund Management LLC acquired a new position in athenahealth during the 2nd quarter valued at about $272,000. Raymond James Financial Services Advisors Inc. acquired a new position in athenahealth during the 2nd quarter valued at about $548,000. Finally, The Manufacturers Life Insurance Company lifted its position in athenahealth by 7.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after purchasing an additional 84 shares during the period.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply